Feedback
BIOCON 
Reputation: 642,681 • Aug 12, 2023 12:26 AM
Competition Commission of India clears Kotak-Biocon Biologics deal
The investment will help Biocon Biologics' acquisition of the biosimilars business of its partner Viatris.
The Economic Times
Vote
Comment
6 Shares
NSE:BIOCON price when posted: 256.2